AMA prescription for private health | AMA (WA)

News

AMA (WA) | Health Insurance

AMA prescription for private health

Monday August 17, 2020

The AMA today released a prescription for private health reform, drawing on demographic, wage, and membership data to propose a suite of policy solutions for Government to implement to reverse the decline of private health insurance.

“The AMA has studied the data and designed detailed, realistic and, most importantly, implementable solutions to ‘stem the tide’ of the insurance decline,” AMA President, Dr Omar Khorshid, said today.

“The AMA’s Prescription for Private Health Insurance clearly shows the negative impact on premiums and affordability that young people leaving the system has had.

“But dig a little deeper and you see the impact that older people entering insurance also creates, compounding the negative effect and creating the ‘spiral’ we constantly hear about.

“Add to that the lacklustre growth in wages compared to the increase in premiums every year, and the size of the challenge facing us becomes clearer.”

AMA analysis indicates that the existing policy settings used by Government are outdated – no longer having the desired effect, due to: changes in the cost of premiums, young Australians earning relatively less than older generations, and Medicare and health fund rebates falling behind the cost of providing services.

“As our research shows, Medicare funding has fallen far behind CPI, and while doctors have held on as long as they can, we are clearly reaching a breaking point,” Dr Khorshid said.

“There is still time to turn around the decline. Policies based on our detailed analysis of the underlying problems, and our recommended solutions, can be developed to address the issues which are failing Australians.

“What is promising is that our analysis indicates that investment made by Government into private health insurance still remains an effective way to fund a system that delivers nearly 60 per cent of our elective surgery.”

The report outlines the necessary changes required to the premium rebate, lifetime health cover loadings, Medicare surcharge levy, and youth discounts to improve the affordability for younger Australians and those on lower incomes, while also incentivising people to maintain their insurance in the longer term.

Further policy reforms are recommended to the design of private health insurance policies, such as a minimum level of benefits being provided to improve transparency for consumers and demonstrate the value for patients.

“It’s also important with such a complex system that we have a strong, independent regulator of private health insurance, so that patients can have peace of mind that their hard-earned contributions are being used effectively,” Dr Khorshid said.

The AMA Prescription for Private Health Insurance is available at https://ama.com.au/article/ama-prescription-private-health

Background

Declining membership

  • The proportion of the population with private hospital insurance has dropped from 47.4 per cent in June 2015 to 43.8 per cent by March 2020 – a total of 3.6 per cent and 19 quarters of continuous decline.
  • Between December 2015 to December 2019, the number of hospital insured young people aged 20-54 years dropped by 4.9 per cent, but rose by 14 per cent for people aged 65 years or older.

Out-of-pocket costs

  • 97.5 per cent of doctors are now billing according to the relevant health insurer gap scheme – the highest proportion in 10 years.
  • Despite a five-year freeze on their incomes, doctors are holding fast and delivering value to patients where they can.
  • For the 2.5 per cent of doctors billing out-of-pocket, the charges for in-hospital services were an average $193 per episode.
  • Medical services account for about 15 per cent of health insurer hospital outlays and 11 per cent of total outlays for an insurer.
  • Medical costs make up only 13.1 per cent of out-of-pocket expenditure for individuals. Nationally, in 2017-18, Australians spent $30.6 billion on out-of-pocket health related expenses:
    • $9.4 billion (30.8 per cent) on non-PBS medications, including over-the-counter medications, vitamins, and health-related products, many of which have no proven efficacy;
    • $6 billion (19.6 per cent) on dental services; and
    • $4 billion (13.1 per cent) on both referred and unreferred medical services (doctors’ fees).